|
Volumn 345, Issue 18, 2001, Pages 1348-1350
|
Single-dose doxycycline for the prevention of lyme disease [1]
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
DOXYCYCLINE;
ANTIINFECTIVE AGENT;
DOSE RESPONSE;
HIGH RISK PATIENT;
HUMAN;
IXODES SCAPULARIS;
LETTER;
LYME DISEASE;
PRIORITY JOURNAL;
PROPHYLAXIS;
TICK BITE;
ANIMAL;
ANTIBIOTIC PROPHYLAXIS;
BITES AND STINGS;
COST BENEFIT ANALYSIS;
ECONOMICS;
NOTE;
RISK;
TICK;
CHILD;
DISEASE TRANSMISSION;
ERYTHEMA CHRONICUM MIGRANS;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ANTIBIOTIC PROPHYLAXIS;
BITES AND STINGS;
COST-BENEFIT ANALYSIS;
DOXYCYCLINE;
HUMANS;
LYME DISEASE;
RISK;
TICKS;
CHILD;
ERYTHEMA CHRONICUM MIGRANS;
|
EID: 0035522299
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200111013451815 Document Type: Letter |
Times cited : (8)
|
References (0)
|